Harm Reduction
A public-health approach that reduces the harms of drug use without requiring abstinence as a precondition for help.
SDG 3 Good Health & Well-beingSDG 10 Reduced InequalitiesWhat is it?
Harm reduction is a set of practical strategies and a guiding philosophy aimed at reducing the negative health, social, and legal consequences of drug use. It meets people where they are and does not require abstinence as a condition of receiving services or respect.
Why does it matter?
In an era of an unpredictable, fentanyl-contaminated drug supply, harm reduction keeps people alive and connected to care long enough to pursue recovery if and when they choose. It treats survival as a prerequisite to everything else.
How does it work?
Harm reduction combines tools and services — naloxone, drug checking such as fentanyl test strips, sterile syringes, overdose education, and low-barrier links to treatment — delivered with dignity and without coercion. Programs prioritize trust so that people at highest risk will actually engage.
Who benefits?
People who use drugs benefit most directly through lower overdose and infection risk, and communities benefit through fewer emergency responses, fewer discarded syringes, and pathways into treatment.
Who may be disadvantaged?
Some residents and officials worry that services may appear to condone drug use; poorly sited or under-resourced programs can generate local friction if community engagement is neglected.
What evidence exists?
SAMHSA identifies harm reduction as a pillar of the federal overdose-prevention strategy, and Harm Reduction International and CDC document that harm-reduction services reduce overdose deaths and disease transmission without increasing drug use.
What tradeoffs exist?
Harm reduction saves lives now and builds trust, but it is sometimes politically contested and may be framed as opposing abstinence-based goals, even though the two approaches can be complementary.
Common misconceptions
Harm reduction does not “enable” or increase drug use; evidence indicates it does not raise use and often increases entry into treatment. It is a bridge to, not a barrier against, recovery.
What you can do next
Explore the specific tools — naloxone distribution, fentanyl test strips, and syringe services programs — and how they fit together in a community response.